Results 211 to 220 of about 273,783 (254)
Correction to: The role of government agencies and other actors in influencing access to medicines in three East African countries. [PDF]
Health Policy Planeuropepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
The new Access to Medicine Index
The Lancet, 2008Tim Reed of Health Action International (Sept 13, p 890) seems less than fully content with the Access to Medicine Index published in June, 2008, because it “has turned out as an attractive new business tool for big pharma.” His disapproval is a bit premature and might be partly based on inaccurate information.
Mohammed K, Ali, K M Venkat, Narayan
+7 more sources
Towards widening access to medicine
Medical Teacher, 2012Dear SirDiversity at medical school would lead to a more culturally sensitive education process, vital in producing competent doctors capable of serving the UK's increasingly heterogeneous populati...
Alhafidz, Hamdan, Edward, Lea
openaire +2 more sources
Patent Funded Access to Medicines
Developing World Bioethics, 2014AbstractInstead of impeding access to essential medicines in developing countries, the essay explores why and how patents can serve as a source of funding for the much needed access to medicine. Instead of a weakening of patents, prolonged protection periods are suggested in circumstances where there is widespread lack of access.
openaire +2 more sources
Access to cancer medicines in India
The Lancet Oncology, 2013An editorial in The Lancet Oncology stated “It could be argued that since access to—and resources for—cancer treatment are so limited in developing countries, the answer lies in a greater reliance on generic drugs.” We agree, but the real question is how best can such generic drug production be stimulated?
Sandeep P, Kishore +2 more
openaire +2 more sources
JAMA, 2013
Advances in the understanding of the genome, combined with affordable sequencing techniques and innovations in drug development, are ushering in an era of molecular diagnostics and individualized therapeutics with the potential to meaningfully enhance human health through effective prevention, diagnosis, and treatment.
Reed V, Tuckson +2 more
openaire +2 more sources
Advances in the understanding of the genome, combined with affordable sequencing techniques and innovations in drug development, are ushering in an era of molecular diagnostics and individualized therapeutics with the potential to meaningfully enhance human health through effective prevention, diagnosis, and treatment.
Reed V, Tuckson +2 more
openaire +2 more sources
Pathways to faster access to medicines
Drug and Therapeutics Bulletin, 2018Before a medicine can be marketed in the UK, marketing authorisation approval is needed from the European Medicines Agency (EMA) or the Medicines and Healthcare products Regulatory Agency (MHRA). However, the time it takes to appraise a medicine is considered by some to delay access to new treatments for people with serious or life-threatening ...
openaire +2 more sources